List of Tables
Table 1. Peptides Biosimilars Market Trends
Table 2. Peptides Biosimilars Market Drivers & Opportunity
Table 3. Peptides Biosimilars Market Challenges
Table 4. Peptides Biosimilars Market Restraints
Table 5. Global Peptides Biosimilars Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peptides Biosimilars Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Peptides Biosimilars Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Peptides Biosimilars Product Type
Table 9. Key Companies Time to Begin Mass Production of Peptides Biosimilars
Table 10. Global Peptides Biosimilars Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptides Biosimilars as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Peptides Biosimilars Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Peptides Biosimilars Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Peptides Biosimilars Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Peptides Biosimilars Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Peptides Biosimilars Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Peptides Biosimilars Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Peptides Biosimilars Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Peptides Biosimilars Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Peptides Biosimilars Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Peptides Biosimilars Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Peptides Biosimilars Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Peptides Biosimilars Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Peptides Biosimilars Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Peptides Biosimilars Sales Value by Region (2019-2024) & (%)
Table 27. Global Peptides Biosimilars Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Peptides Biosimilars Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Peptides Biosimilars Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Peptides Biosimilars Sales Value, (2025-2030) & (US$ Million)
Table 31. Sandoz Basic Information List
Table 32. Sandoz Description and Business Overview
Table 33. Sandoz Peptides Biosimilars Products, Services and Solutions
Table 34. Revenue (US$ Million) in Peptides Biosimilars Business of Sandoz (2019-2024)
Table 35. Sandoz Recent Developments
Table 36. Pfizer Basic Information List
Table 37. Pfizer Description and Business Overview
Table 38. Pfizer Peptides Biosimilars Products, Services and Solutions
Table 39. Revenue (US$ Million) in Peptides Biosimilars Business of Pfizer (2019-2024)
Table 40. Pfizer Recent Developments
Table 41. Teva Pahrmaceutical Basic Information List
Table 42. Teva Pahrmaceutical Description and Business Overview
Table 43. Teva Pahrmaceutical Peptides Biosimilars Products, Services and Solutions
Table 44. Revenue (US$ Million) in Peptides Biosimilars Business of Teva Pahrmaceutical (2019-2024)
Table 45. Teva Pahrmaceutical Recent Developments
Table 46. Celltrion Basic Information List
Table 47. Celltrion Description and Business Overview
Table 48. Celltrion Peptides Biosimilars Products, Services and Solutions
Table 49. Revenue (US$ Million) in Peptides Biosimilars Business of Celltrion (2019-2024)
Table 50. Celltrion Recent Developments
Table 51. Biocon Basic Information List
Table 52. Biocon Description and Business Overview
Table 53. Biocon Peptides Biosimilars Products, Services and Solutions
Table 54. Revenue (US$ Million) in Peptides Biosimilars Business of Biocon (2019-2024)
Table 55. Biocon Recent Developments
Table 56. Amgen Basic Information List
Table 57. Amgen Description and Business Overview
Table 58. Amgen Peptides Biosimilars Products, Services and Solutions
Table 59. Revenue (US$ Million) in Peptides Biosimilars Business of Amgen (2019-2024)
Table 60. Amgen Recent Developments
Table 61. Samsung Biologics Basic Information List
Table 62. Samsung Biologics Description and Business Overview
Table 63. Samsung Biologics Peptides Biosimilars Products, Services and Solutions
Table 64. Revenue (US$ Million) in Peptides Biosimilars Business of Samsung Biologics (2019-2024)
Table 65. Samsung Biologics Recent Developments
Table 66. Mylan Basic Information List
Table 67. Mylan Description and Business Overview
Table 68. Mylan Peptides Biosimilars Products, Services and Solutions
Table 69. Revenue (US$ Million) in Peptides Biosimilars Business of Mylan (2019-2024)
Table 70. Mylan Recent Developments
Table 71. Dr. Reddy's Laboratories Basic Information List
Table 72. Dr. Reddy's Laboratories Description and Business Overview
Table 73. Dr. Reddy's Laboratories Peptides Biosimilars Products, Services and Solutions
Table 74. Revenue (US$ Million) in Peptides Biosimilars Business of Dr. Reddy's Laboratories (2019-2024)
Table 75. Dr. Reddy's Laboratories Recent Developments
Table 76. Stada Arzneimittel AG Basic Information List
Table 77. Stada Arzneimittel AG Description and Business Overview
Table 78. Stada Arzneimittel AG Peptides Biosimilars Products, Services and Solutions
Table 79. Revenue (US$ Million) in Peptides Biosimilars Business of Stada Arzneimittel AG (2019-2024)
Table 80. Stada Arzneimittel AG Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Peptides Biosimilars Downstream Customers
Table 84. Peptides Biosimilars Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Peptides Biosimilars Product Picture
Figure 2. Global Peptides Biosimilars Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 4. Peptides Biosimilars Report Years Considered
Figure 5. Global Peptides Biosimilars Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peptides Biosimilars Revenue in 2023
Figure 7. Peptides Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Glucagon Picture
Figure 9. Calcitonin Picture
Figure 10. Global Peptides Biosimilars Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Peptides Biosimilars Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Oncology
Figure 13. Product Picture of Chronic Diseases
Figure 14. Product Picture of Autoimmune Diseases
Figure 15. Product Picture of Blood Disorders
Figure 16. Product Picture of Growth Hormone Deficiency
Figure 17. Product Picture of Infectious Diseases
Figure 18. Product Picture of Other Diseases
Figure 19. Global Peptides Biosimilars Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Peptides Biosimilars Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Peptides Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Peptides Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Peptides Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Peptides Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Peptides Biosimilars Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Peptides Biosimilars Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Peptides Biosimilars Sales Value (%), (2019-2030)
Figure 32. United States Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 38. China Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 40. China Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 50. India Peptides Biosimilars Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Peptides Biosimilars Sales Value by Type (%), 2023 VS 2030
Figure 52. India Peptides Biosimilars Sales Value by Application (%), 2023 VS 2030
Figure 53. Peptides Biosimilars Industrial Chain
Figure 54. Peptides Biosimilars Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
